VENCLEXTA™ is a first-in-class treatment that targets BCL-2 to help restore the process of apoptosis 1

BCL-2, which inhibits apoptosis, is overexpressed in CLL cells and has been associated with resistance to chemotherapy

MOA Video

MOA Images